Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study. [electronic resource]
- Alimentary pharmacology & therapeutics Sep 2011
- 586 p. digital
Publication Type: Letter; Comment
1365-2036
10.1111/j.1365-2036.2011.04778.x doi
Antibodies, Monoclonal--therapeutic use Crohn Disease--diagnosis Feces--chemistry Female Gastrointestinal Agents--therapeutic use Humans Leukocyte L1 Antigen Complex--metabolism Male Tumor Necrosis Factor-alpha--therapeutic use